ACM
PRAX icon

ADAR1 Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

ADAR1 Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9M Buy
74,253
+72,753
+4,850% +$23M 1.14% 17
2026
Q1 		$483K Hold
1,500
– – 0.03% 203
2025
Q4 		$442K Buy
+1,500
New +$279K 0.03% 192

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ADAR1 Capital Management's PRAX Position: Q2 2026 in Review

ADAR1 Capital Management increased its Praxis Precision Medicines (PRAX) stake by 4,850% in Q2 2026, buying an estimated $23M and bringing the position to 74,253 shares worth $24.9M. The position accounts for 1.14% of the portfolio, ranked #17.

ADAR1 Capital Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • ADAR1 Capital Management held 74,253 shares of Praxis Precision Medicines worth $24.9M as of Q2 2026.
  • ADAR1 Capital Management bought 72,753 Praxis Precision Medicines shares in Q2 2026, an estimated $23M.
  • Praxis Precision Medicines made up 1.14% of ADAR1 Capital Management's portfolio in Q2 2026, its #17 holding.
  • ADAR1 Capital Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.